Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome.
Collins
P
P
Arthur Bloom Haemophilia Centre, University Hospital of Wales, Cardiff, UK.
Budde
U
U
Rand
J H
JH
Federici
A B
AB
Kessler
C M
CM
D000792:Angiography / Q000295:instrumentation; D001323:Autoantibodies / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002985:Clinical Protocols; D006395:Hemarthrosis / Q000188:drug therapy; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D010818:Practice Patterns, Physicians' / Q000639:trends; D011994:Recombinant Proteins / Q000627:therapeutic use*; D012307:Risk Factors; D055502:Secondary Prevention; D014841:von Willebrand Factor / Q000627:therapeutic use*
D001323:Autoantibodies; D011994:Recombinant Proteins; D014841:von Willebrand Factor